FDA Postpones Capitol Hill Meetings on User Fees, Pending White House Review

The FDA had to postpone meetings with Capitol Hill staff to discuss upcoming user fee legislation, after the Trump Administration directed agencies to halt correspondence with members of Congress.
Source: Drug Industry Daily